Caredx Inc (CDNA)

May 05, 2026

[144] CareDx, Inc. SEC Filing - Stock Titan

May 05, 2026

May 05, 2026

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The National Law Review

May 05, 2026

May 04, 2026

CareDx (CDNA) General Counsel has 2,873 shares withheld to cover RSU taxes - Stock Titan

May 04, 2026

May 04, 2026

How Investors Are Reacting To CareDx (CDNA) Profitability Milestone And Higher 2026 Revenue Guidance - Sahm

May 04, 2026

May 03, 2026

CareDx (NASDAQ:CDNA) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat

May 03, 2026

May 02, 2026

MSN Money - MSN

May 02, 2026

May 01, 2026

23 new CareDx hires receive 63,856 stock units under Nasdaq rule - Stock Titan

May 01, 2026

May 01, 2026

CareDx sharpens focus on core testing services - MSN

May 01, 2026

May 01, 2026

CareDx (CDNA) Q2 2025 Earnings Transcript - AOL.com

May 01, 2026

Apr 30, 2026

CareDx : 2025 Annual Report - marketscreener.com

Apr 30, 2026

Apr 30, 2026

CareDx : 2026 Proxy Statement - marketscreener.com

Apr 30, 2026

Apr 30, 2026

Analysts Conflicted on These Healthcare Names: CareDx (CDNA), Biogen (BIIB) and Guardant Health (GH) - The Globe and Mail

Apr 30, 2026

Apr 30, 2026

H.C. Wainwright reiterates Neutral rating on CareDx stock By Investing.com - Investing.com Australia

Apr 30, 2026

Apr 30, 2026

H.C. Wainwright reiterates Neutral rating on CareDx stock - Investing.com

Apr 30, 2026

Apr 30, 2026

Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX), Stryker (SYK) and CareDx (CDNA) - The Globe and Mail

Apr 30, 2026

Apr 30, 2026

CareDx Acquires Navaris and Divests Lab Products to Accelerate Growth - HarianBasis.co

Apr 30, 2026

Apr 30, 2026

Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and Ultragenyx Pharmaceutical (RARE) - The Globe and Mail

Apr 30, 2026

Apr 29, 2026

CareDx Earnings Call: Growth Accelerates Amid Bold Pivot - TipRanks

Apr 29, 2026

Apr 29, 2026

CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing - The National Law Review

Apr 29, 2026

Apr 29, 2026

Q1 2026 Presentation (04/28/2026 00: 00 - marketscreener.com

Apr 29, 2026

Apr 29, 2026

CareDx (NASDAQ:CDNA) Trading Down 8.7%What's Next? - MarketBeat

Apr 29, 2026

Apr 29, 2026

CareDx sharpens precision medicine focus with $260m Naveris acquisition - Yahoo Finance

Apr 29, 2026

Apr 29, 2026

Caredx to acquire Naveris for up to $260 million - BioWorld News

Apr 29, 2026

Apr 29, 2026

CareDx : ESG Report (CareDx 2026 ESG Report) - marketscreener.com

Apr 29, 2026

Apr 29, 2026

CDNA Maintained by BTIG -- Price Target Raised to $28.00 - GuruFocus

Apr 29, 2026

Apr 29, 2026

CareDx to Acquire Oncology Diagnostics Company Naveris for $160 Million - Clinical Lab Products

Apr 29, 2026

Apr 29, 2026

CareDx, Inc Q1 2026 Earnings Call Summary - Yahoo Finance

Apr 29, 2026

Apr 29, 2026

CareDx (NASDAQ:CDNA) Price Target Raised to $28.00 at BTIG Research - MarketBeat

Apr 29, 2026

Apr 29, 2026

CareDx, Inc (NASDAQ:CDNA) Q1 2026 Earnings Call Transcript - Insider Monkey

Apr 29, 2026

Apr 29, 2026

BTIG raises CareDx stock price target on oncology diagnostics deal - Investing.com UK

Apr 29, 2026

Apr 29, 2026

BTIG raises CareDx stock price target on oncology diagnostics deal By Investing.com - Investing.com South Africa

Apr 29, 2026

Apr 29, 2026

CareDx Inc (CDNA) Q1 2026 Earnings Call Highlights: Strong Reven - GuruFocus

Apr 29, 2026

Apr 29, 2026

CareDx Announces First Quarter 2026 Financial Results - BioSpace

Apr 29, 2026

Apr 29, 2026

CareDx Q1 2026 Earnings Call Transcript - MarketBeat

Apr 29, 2026

Apr 28, 2026

CareDx to acquire Naveris for $160M up-front, $100M in revenue milestones - TipRanks

Apr 28, 2026

Apr 28, 2026

CareDx to acquire oncology diagnostics firm Naveris for $160M By Investing.com - Investing.com South Africa

Apr 28, 2026

Apr 28, 2026

CareDx (CDNA) Q1 2026: EPS $0.05 Beats -$0.03 Est; Revenue $118M - GuruFocus

Apr 28, 2026

Apr 28, 2026

CareDx to Acquire Naveris to Expand Into Cancer MRD Testing - Yahoo Finance

Apr 28, 2026

Apr 28, 2026

CDNA Adjusts 2026 EBITDA Forecast to $43M-$57M Range - GuruFocus

Apr 28, 2026

Apr 28, 2026

CDNA Expands Precision Medicine Services with Naveris Acquisitio - GuruFocus

Apr 28, 2026

Apr 28, 2026

Earnings call transcript: CareDx Q1 2026 earnings beat expectations By Investing.com - Investing.com India

Apr 28, 2026

Apr 28, 2026

CareDx, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:CDNA) 2026-04-28 - Seeking Alpha

Apr 28, 2026

Apr 28, 2026

CareDx (CDNA) Q1 2026 Earnings Call Transcript - The Motley Fool

Apr 28, 2026

Apr 28, 2026

CareDx Q1 Earnings Call Highlights - MarketBeat

Apr 28, 2026

Apr 28, 2026

CDNA Reports Strong Q1 Revenue Growth and Strategic Developments - GuruFocus

Apr 28, 2026

Apr 28, 2026

Q1 2026 CareDx Earnings Presentation (04/28/2026 00: 00 - marketscreener.com

Apr 28, 2026

Apr 28, 2026

CareDx (NASDAQ:CDNA) Releases Earnings Results, Beats Estimates By $0.21 EPS - MarketBeat

Apr 28, 2026

Apr 28, 2026

Earnings call transcript: CareDx Q1 2026 earnings beat expectations - Investing.com

Apr 28, 2026

Apr 28, 2026

CareDx (CDNA) Q1 Earnings and Revenues Top Estimates - Yahoo Finance

Apr 28, 2026

Apr 28, 2026

(CDNA) CareDx Now Expects Full Year 2026 Revenue Range $447 Million$465 Million, vs. FactSet Est of $432 Million - marketscreener.com

Apr 28, 2026